Pfizer-Allergan deal is a ‘travesty’ - Icahn
Activist investor Carl Icahn argues that deal will open the floodgates for other companies to leave the US
Investors and directors discover it’s good to talk
The Bottom Line: a little communication with shareholders would go a long way
Battle for Dell yet to power down
When a takeover deal was announced in February, Dell looked set to be handed over to its founder, but billionaire Carl Icahn remains resolute in his opposition
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices